Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study.
Meca-Lallana JE, Prieto González JM, Caminero Rodríguez AB, Olascoaga Urtaza J, Alonso AM, Durán Ferreras E, Espinosa R, Dotor J, Romera M, Ares Luque A, Pérez Ruiz D, Calles C, Hernández MA, Hervás García M, Mendoza Rodríguez A, Berdei Montero Y, Téllez N, Herrera Varó N, Sotoca J, Presas-Rodríguez S, Querol Gutierrez LA, Hervás Pujol M, Batlle Nadal J, Martín Ozaeta G, Gubieras Lillo L, Martínez Yélamos S, Ramió-Torrentà L, Mallada Frechin J, Belenguer Benavides A, Gascón-Giménez F, Casanova B, Landete Pascual L, Berenguer L, Navarro L, Gómez Gutierrez M, Durán C, Rodríguez Regal A, Álvarez E, García-Estévez DA, López Real AM, Llaneza González MA, Marzo Sola ME, Sánchez-Menoyo JL, Oterino A, Villaverde González R, Castillo-Triviño T, Álvarez de Arcaya A, Llarena C. Meca-Lallana JE, et al. Among authors: llaneza gonzalez ma. Neurol Ther. 2023 Dec;12(6):2177-2193. doi: 10.1007/s40120-023-00557-7. Epub 2023 Oct 20. Neurol Ther. 2023. PMID: 37861931 Free PMC article.
Best practices in phase III clinical trials on DMTs for multiple sclerosis: a systematic analysis and appraisal of published trials.
Mascarenas-Garcia M, Rivero-de-Aguilar A, Pérez-Ríos M, Ruano-Raviña A, Llaneza-Gonzalez MA, Candal-Pedreira C, Rey-Brandariz J, Varela-Lema L. Mascarenas-Garcia M, et al. Among authors: llaneza gonzalez ma. J Neurol Neurosurg Psychiatry. 2024 Mar 13;95(4):333-341. doi: 10.1136/jnnp-2023-331733. J Neurol Neurosurg Psychiatry. 2024. PMID: 37541785
Defining a standard set of health outcomes for patients with relapsing-remitting multiple sclerosis.
Llaneza González M, Carrascal Rueda P, Delgado Sánchez O, Borges Guerra M, Rodríguez Antigüedad A, Morell Baladrón A, Becerril Ríos N, Rovira À, Meca Lallana V, Benedito-Palos L, Comellas M, Vilanova D, Echeto A, Pérez X, Oreja-Guevara C. Llaneza González M, et al. Mult Scler Relat Disord. 2024 Apr;84:105501. doi: 10.1016/j.msard.2024.105501. Epub 2024 Feb 13. Mult Scler Relat Disord. 2024. PMID: 38401203 Free article. Review.
SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry.
Arrambide G, Llaneza-González MÁ, Costa-Frossard França L, Meca-Lallana V, Díaz EF, Moreno-Torres I, García-Domínguez JM, Ortega-Suero G, Ayuso-Peralta L, Gómez-Moreno M, Sotoca-Fernández JJ, Caminero-Rodríguez AB, Rodríguez de Antonio LA, Corujo-Suárez M, Otano-Martínez MA, Pérez-Miralles FC, Reyes-Garrido V, Ayuso-Blanco T, Balseiro-Gómez JJ, Muñoz-Pasadas M, Pérez-Molina I, Arnal-García C, Domingo-Santos Á, Guijarro-Castro C, Íñiguez-Martínez C, Téllez Lara N, Castellanos-Pinedo F, Castillo-Triviño T, Cerdán-Santacruz DM, Pérez-Sempere Á, Torres BS, Álvarez de Arcaya A, Costa-Arpín E, Durán-Ferreras E, Fragoso-Martínez M, González-Platas M, Landete Pascual L, Millán-Pascual J, Oreja-Guevara C, Meca-Lallana JE. Arrambide G, et al. Among authors: llaneza gonzalez ma. Neurol Neuroimmunol Neuroinflamm. 2021 Jun 24;8(5):e1024. doi: 10.1212/NXI.0000000000001024. Print 2021 Jul. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34168057 Free PMC article.
[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Galicia].
Pato-Pato A, Midaglia L, Costa-Arpin E, Rodriguez-Regal A, Puy-Nunez A, Rodriguez-Rodriguez M, Lopez-Real A, Llaneza-Gonzalez MA, Garcia-Estevez DA, Moreno-Carretero MJ, Escriche-Jaime D, Aguado-Valcarcel ML, Munoz D, Prieto JM, Lorenzo-Gonzalez JR, Amigo-Jorrin MC. Pato-Pato A, et al. Among authors: llaneza gonzalez ma. Rev Neurol. 2016 Sep 5;63(s01):S13-S18. Rev Neurol. 2016. PMID: 27658431 Spanish.
[Sensory symptoms in Parkinson's disease].
Santos-García D, Aneiros-Díaz A, Macias-Arribi M, Llaneza-González MA, Abella-Corral J, Santos-Canelles H. Santos-García D, et al. Among authors: llaneza gonzalez ma. Rev Neurol. 2010 Feb 8;50 Suppl 2:S65-74. Rev Neurol. 2010. PMID: 20205145 Free article. Review. Spanish.
14 results